
Sign up to save your podcasts
Or


Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001161?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001161?ecd=bdc_podcast_libsyn_mscpedu

137 Listeners

698 Listeners

497 Listeners

168 Listeners

103 Listeners

882 Listeners

14 Listeners

16 Listeners

292 Listeners

262 Listeners

3,348 Listeners

1,145 Listeners

193 Listeners

92 Listeners

515 Listeners

369 Listeners

172 Listeners

61 Listeners

8 Listeners

425 Listeners